WSU-inspired national gene-editing task force begins work
With the world’s population projected to reach ~10 billion in 30 years, scientists are working to use genetic technologies to address future food security problems.
Study finds fatty acid that kills cancer cells
Researchers have demonstrated that a fatty acid called dihomogamma-linolenic acid, or DGLA, can kill human cancer cells.
Students, grads fight COVID‑19 this summer
While many Washington State University graduates celebrated the coming summer break, some stuck around to fight the COVID-19 pandemic.
Gene-Editing in Animal Agriculture Task Force Established
Jon Oatley selected to serve on the APLU and the AAVMC Gene Editing Task Force.
WSU senior headed to Wales as a Fulbright Student
WSU senior biology and music double major and future veterinarian Thomas LeClair is the 2020 recipient of a Fulbright Student Award.
The Scientists Taking Atomic-Level Pictures Of The Coronavirus
Even before the word “coronavirus” inserted itself into the nation’s vocabulary, a national group of scientists jumped into the effort to start revealing those protein structures, structures that hold the keys to vaccines and treatments.
SMB Alumna Jen Adair Garners Fred Hutch Gene Therapy Chair
Congratulations to SMB alumna Dr. Jen Adair for garnering a distinguished chair at the Fred Hutch and speaking to the annual AAAS meeting in Seattle this weekend. Dr. Adair completed her doctoral training in Genetics and Cell Biology in 2005
BPAs May Be Far More Prevalent in Humans Than Previously Thought.
A new study finds that the tools used to screen for the chemical Bisphenol A (BPA) in the human body may be vastly underestimating its prevalence.
Understanding immunity to improve health
Just a few short hours after illness-causing bacteria enter the human body, a sophisticated defense system goes to work. The immune system quickly recognizes the foreign invaders and sends a well-orchestrated, frontline defense.
Study finds BPA levels in humans dramatically underestimated
Researchers have developed a more accurate method of measuring bisphenol A (BPA) levels in humans and found that exposure to the endocrine-disrupting chemical is far higher than previously assumed.
The study, published in the journal The Lancet Diabetes & Endocrinology on Dec. 5, provides the first evidence that the measurements relied upon by regulatory agencies, including the U.S. Food and Drug Administration, are flawed, underestimating exposure levels by as much as 44 times.